← Leaderboards
Francisco Lopera
University Of California, San Francisco
$10,359,464
Attributed
$32,321,580
Total exposure
3
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $15.3M · FY2012–23$20M$15M$10M$5M$0
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$32,321,580 · 3
By mechanism
R01$17,068,630 · 2
RF1$15,252,950 · 1
Top collaborators
- Eric M Reiman6 shared
- Pierre N. Tariot6 shared
- Nilton Custodio4 shared
- Agustin M. Ibanez4 shared
- Bruce L Miller4 shared
- Katherine Laurel Possin4 shared
- Jennifer S Yokoyama4 shared
- Leonel Tadao Takada3 shared
Most similar at University Of California, San Francisco
Same institution · by research overlap
- Laura Fejerman$6,376,255
- Bruce L Miller$34,542,477
- Ajit Harishkumar Goenka$3,380,410
- Orion D Weiner$14,865,661
- Zhen Jane Wang$4,501,373
Others in their field
Top investigators on “Alzheimer&Apos”
- Jose A Luchsinger · Columbia University Health Sciences$56,595,040
- Eric M Reiman · Banner Health$48,982,487
- Yadong Huang · J. David Gladstone Institutes$40,311,515
- Lindsay A. Farrer · Boston University Medical Campus$34,189,802
- David M Holtzman · Washington University$28,985,806
- Michael W Weiner · Northern California Institute Res &Educ$28,197,224
Research focus
Alzheimer&AposS DiseasePathway InteractionsBrain ImagingCerebrumCognitiveParticipantColombiaS Disease RiskEuropeanEvaluationGeneticSamplingGenetic RiskBaseCognitive TestingApolipoprotein E-4Impaired CognitionInheritedBiologicalHomozygoteInterestFluorodeoxyglucose Positron Emission TomographyAmyloid
Grant awards (10)
US-South American Initiative for Genetic-Neural-Behavioral Interactions in Human Neurodegenerative Research$512,850
R01 · FY2023 · AG
Alzheimer's Prevention Initiative ADAD Colombia Trial$5,754,078
R01 · FY2022 · AG
Alzheimer's Prevention Initiative ADAD Colombia Trial$2,364,038
R01 · FY2021 · AG
US-South American Initiative for Genetic-Neural-Behavioral Interactions in Human Neurodegenerative Research$521,480
R01 · FY2021 · AG
Alzheimer's Prevention Initiative ADAD Colombia Trial$2,216,620
R01 · FY2020 · AG
US-South American Initiative for Genetic-Neural-Behavioral Interactions in Human Neurodegenerative Research$807,005
R01 · FY2020 · AG
US-South American Initiative for Genetic-Neural-Behavioral Interactions in Human Neurodegenerative Research$334,244
R01 · FY2019 · AG
Alzheimer's Prevention Initiative ADAD Colombia Trial$2,207,066
R01 · FY2018 · AG
Alzheimer's Prevention Initiative ADAD Colombia Trial$2,351,249
R01 · FY2017 · AG
Alzheimer's Prevention Initiative$15,252,950
RF1 · FY2012 · AG